In summary, we demonstrated that the CD68+ hepatic macrophages in terminal EBOV-infected macaques include a mix of inflammatory and non-inflammatory phenotypes that express CD163, a biomarker associated with macrophage activation syndrome, but lack significant expression of many traditional M1 and M2-related genes. Here, CD163 is linked to macrophage activation syndrome.